SCHEDULE 13G
(Rule 13d-102)

INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b),
(c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (b)
(Amendment No.     )*

(Name of Issuer)

(Title of Class of Securities)

(CUSIP Number)

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

(1)   This Schedule 13G is filed by Pacven Walden Ventures V, L.P. (“Pacven V”), Pacven Walden Ventures Parallel V-A C.V. (“Pacven Parallel V-A”), Pacven Walden Ventures Parallel V-B C.V. (“Pacven Parallel V-B”), Pacven Walden Ventures V Associates Fund, L.P. (“Pacven Associates V”), Pacven Walden Ventures V-QP Associates Fund, L.P. (“Pacven Associates V-QP”), Asian Venture Capital Investment Corp. (“Asian Venture”), International Venture Capital Investment Corp. (“International Venture”), International Venture Capital Investment III Corp. (“International Venture III”), Seed Ventures III Pte Ltd. (“Seed Ventures”), Pacven Walden Ventures VI, L.P. (“Pacven VI”), Pacven Walden Ventures Parallel VI, L.P. (“Pacven Parallel VI”), Lip-Bu Tan (“Tan”), Andrew Kau (“Kau”), Hock Voon Loo (“Loo”), Brian Chiang (“Chiang”) and Mary Coleman (“Coleman” and together with Pacven V, Pacven Parallel V-A, Pacven Parallel V-B, Pacven Associates V, Pacven Associates V-QP, Asian Venture, International Venture, International Venture III, Seed Ventures, Pacven VI, Pacven Parallel VI, Tan, Kau, Loo and Chiang, collectively, the “Reporting Persons”).  The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

(2)   On April 6, 2011, the reporting person sold 253,597 shares in a registered public offering and currently holds 2,021,291 shares of Common Stock, representing a beneficial ownership of 7.29%, calculated based upon 27,729,683 shares of Common Stock outstanding as of November 2, 2011 as set forth in the Issuer’s most recent 10-Q filed with the Securities and Exchange Commission on November 4, 2011.

(3)   This percentage is calculated based upon 25,388,810 shares of Common Stock outstanding as of February 23, 2011 as set forth in the Issuer’s most recent 10-K filed with the Securities and Exchange Commissions on March 7, 2011.

2

(1)   This Schedule 13G is filed by Pacven Walden Ventures V, L.P. (“Pacven V”), Pacven Walden Ventures Parallel V-A C.V. (“Pacven Parallel V-A”), Pacven Walden Ventures Parallel V-B C.V. (“Pacven Parallel V-B”), Pacven Walden Ventures V Associates Fund, L.P. (“Pacven Associates V”), Pacven Walden Ventures V-QP Associates Fund, L.P. (“Pacven Associates V-QP”), Asian Venture Capital Investment Corp. (“Asian Venture”), International Venture Capital Investment Corp. (“International Venture”), International Venture Capital Investment III Corp. (“International Venture III”), Seed Ventures III Pte Ltd. (“Seed Ventures”), Pacven Walden Ventures VI, L.P. (“Pacven VI”), Pacven Walden Ventures Parallel VI, L.P. (“Pacven Parallel VI”), Lip-Bu Tan (“Tan”), Andrew Kau (“Kau”), Hock Voon Loo (“Loo”), Brian Chiang (“Chiang”) and Mary Coleman (“Coleman” and together with Pacven V, Pacven Parallel V-A, Pacven Parallel V-B, Pacven Associates V, Pacven Associates V-QP, Asian Venture, International Venture, International Venture III, Seed Ventures, Pacven VI, Pacven Parallel VI, Tan, Kau, Loo and Chiang, collectively, the “Reporting Persons”).  The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

(2)   On April 6, 2011, the reporting person sold 5,844 shares in a registered public offering and currently holds 46,579 shares of Common Stock, representing a beneficial ownership of 0.2%, calculated based upon 27,729,683 shares of Common Stock outstanding as of November 2, 2011 as set forth in the Issuer’s most recent 10-Q filed with the Securities and Exchange Commission on November 4, 2011.

(3)   This percentage is calculated based upon 25,388,810 shares of Common Stock outstanding as of February 23, 2011 as set forth in the Issuer’s most recent 10-K filed with the Securities and Exchange Commissions on March 7, 2011.

3

(1)   This Schedule 13G is filed by Pacven Walden Ventures V, L.P. (“Pacven V”), Pacven Walden Ventures Parallel V-A C.V. (“Pacven Parallel V-A”), Pacven Walden Ventures Parallel V-B C.V. (“Pacven Parallel V-B”), Pacven Walden Ventures V Associates Fund, L.P. (“Pacven Associates V”), Pacven Walden Ventures V-QP Associates Fund, L.P. (“Pacven Associates V-QP”), Asian Venture Capital Investment Corp. (“Asian Venture”), International Venture Capital Investment Corp. (“International Venture”), International Venture Capital Investment III Corp. (“International Venture III”), Seed Ventures III Pte Ltd. (“Seed Ventures”), Pacven Walden Ventures VI, L.P. (“Pacven VI”), Pacven Walden Ventures Parallel VI, L.P. (“Pacven Parallel VI”), Lip-Bu Tan (“Tan”), Andrew Kau (“Kau”), Hock Voon Loo (“Loo”), Brian Chiang (“Chiang”) and Mary Coleman (“Coleman” and together with Pacven V, Pacven Parallel V-A, Pacven Parallel V-B, Pacven Associates V, Pacven Associates V-QP, Asian Venture, International Venture, International Venture III, Seed Ventures, Pacven VI, Pacven Parallel VI, Tan, Kau, Loo and Chiang, collectively, the “Reporting Persons”).  The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

(2)   On April 6, 2011, the reporting person sold 5,844 shares in a registered public offering and currently holds 46,579 shares of Common Stock, representing a beneficial ownership of 0.2%, calculated based upon 27,729,683 shares of Common Stock outstanding as of November 2, 2011 as set forth in the Issuer’s most recent 10-Q filed with the Securities and Exchange Commission on November 4, 2011.

(3)   This percentage is calculated based upon 25,388,810 shares of Common Stock outstanding as of February 23, 2011 as set forth in the Issuer’s most recent 10-K filed with the Securities and Exchange Commissions on March 7, 2011.

4

(1)   This Schedule 13G is filed by Pacven Walden Ventures V, L.P. (“Pacven V”), Pacven Walden Ventures Parallel V-A C.V. (“Pacven Parallel V-A”), Pacven Walden Ventures Parallel V-B C.V. (“Pacven Parallel V-B”), Pacven Walden Ventures V Associates Fund, L.P. (“Pacven Associates V”), Pacven Walden Ventures V-QP Associates Fund, L.P. (“Pacven Associates V-QP”), Asian Venture Capital Investment Corp. (“Asian Venture”), International Venture Capital Investment Corp. (“International Venture”), International Venture Capital Investment III Corp. (“International Venture III”), Seed Ventures III Pte Ltd. (“Seed Ventures”), Pacven Walden Ventures VI, L.P. (“Pacven VI”), Pacven Walden Ventures Parallel VI, L.P. (“Pacven Parallel VI”), Lip-Bu Tan (“Tan”), Andrew Kau (“Kau”), Hock Voon Loo (“Loo”), Brian Chiang (“Chiang”) and Mary Coleman (“Coleman” and together with Pacven V, Pacven Parallel V-A, Pacven Parallel V-B, Pacven Associates V, Pacven Associates V-QP, Asian Venture, International Venture, International Venture III, Seed Ventures, Pacven VI, Pacven Parallel VI, Tan, Kau, Loo and Chiang, collectively, the “Reporting Persons”).  The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

(2)   On April 6, 2011, the reporting person sold 621 shares in a registered public offering and currently holds 4,955 shares of Common Stock, representing a beneficial ownership of 0.2%, calculated based upon 27,729,683 shares of Common Stock outstanding as of November 2, 2011 as set forth in the Issuer’s most recent 10-Q filed with the Securities and Exchange Commission on November 4, 2011.

(3)   This percentage is calculated based upon 25,388,810 shares of Common Stock outstanding as of February 23, 2011 as set forth in the Issuer’s most recent 10-K filed with the Securities and Exchange Commissions on March 7, 2011.

5

(1)   This Schedule 13G is filed by Pacven Walden Ventures V, L.P. (“Pacven V”), Pacven Walden Ventures Parallel V-A C.V. (“Pacven Parallel V-A”), Pacven Walden Ventures Parallel V-B C.V. (“Pacven Parallel V-B”), Pacven Walden Ventures V Associates Fund, L.P. (“Pacven Associates V”), Pacven Walden Ventures V-QP Associates Fund, L.P. (“Pacven Associates V-QP”), Asian Venture Capital Investment Corp. (“Asian Venture”), International Venture Capital Investment Corp. (“International Venture”), International Venture Capital Investment III Corp. (“International Venture III”), Seed Ventures III Pte Ltd. (“Seed Ventures”), Pacven Walden Ventures VI, L.P. (“Pacven VI”), Pacven Walden Ventures Parallel VI, L.P. (“Pacven Parallel VI”), Lip-Bu Tan (“Tan”), Andrew Kau (“Kau”), Hock Voon Loo (“Loo”), Brian Chiang (“Chiang”) and Mary Coleman (“Coleman” and together with Pacven V, Pacven Parallel V-A, Pacven Parallel V-B, Pacven Associates V, Pacven Associates V-QP, Asian Venture, International Venture, International Venture III, Seed Ventures, Pacven VI, Pacven Parallel VI, Tan, Kau, Loo and Chiang, collectively, the “Reporting Persons”).  The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

(2)   On April 6, 2011, the reporting person sold 4,088 shares in a registered public offering and currently holds 32,584 shares of Common Stock, representing a beneficial ownership of 0.1%, calculated based upon 27,729,683 shares of Common Stock outstanding as of November 2, 2011 as set forth in the Issuer’s most recent 10-Q filed with the Securities and Exchange Commission on November 4, 2011.

(3)   This percentage is calculated based upon 25,388,810 shares of Common Stock outstanding as of February 23, 2011 as set forth in the Issuer’s most recent 10-K filed with the Securities and Exchange Commissions on March 7, 2011.

6

(1)   This Schedule 13G is filed by Pacven Walden Ventures V, L.P. (“Pacven V”), Pacven Walden Ventures Parallel V-A C.V. (“Pacven Parallel V-A”), Pacven Walden Ventures Parallel V-B C.V. (“Pacven Parallel V-B”), Pacven Walden Ventures V Associates Fund, L.P. (“Pacven Associates V”), Pacven Walden Ventures V-QP Associates Fund, L.P. (“Pacven Associates V-QP”), Asian Venture Capital Investment Corp. (“Asian Venture”), International Venture Capital Investment Corp. (“International Venture”), International Venture Capital Investment III Corp. (“International Venture III”), Seed Ventures III Pte Ltd. (“Seed Ventures”), Pacven Walden Ventures VI, L.P. (“Pacven VI”), Pacven Walden Ventures Parallel VI, L.P. (“Pacven Parallel VI”), Lip-Bu Tan (“Tan”), Andrew Kau (“Kau”), Hock Voon Loo (“Loo”), Brian Chiang (“Chiang”) and Mary Coleman (“Coleman” and together with Pacven V, Pacven Parallel V-A, Pacven Parallel V-B, Pacven Associates V, Pacven Associates V-QP, Asian Venture, International Venture, International Venture III, Seed Ventures, Pacven VI, Pacven Parallel VI, Tan, Kau, Loo and Chiang, collectively, the “Reporting Persons”).  The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

(2)   On April 6, 2011, the reporting person sold 6,601 shares in a registered public offering and currently holds 52,609 shares of Common Stock, representing a beneficial ownership of 0.2%, calculated based upon 27,729,683 shares of Common Stock outstanding as of November 2, 2011 as set forth in the Issuer’s most recent 10-Q filed with the Securities and Exchange Commission on November 4, 2011.

(3)   This percentage is calculated based upon 25,388,810 shares of Common Stock outstanding as of February 23, 2011 as set forth in the Issuer’s most recent 10-K filed with the Securities and Exchange Commissions on March 7, 2011.

7

(1)   This Schedule 13G is filed by Pacven Walden Ventures V, L.P. (“Pacven V”), Pacven Walden Ventures Parallel V-A C.V. (“Pacven Parallel V-A”), Pacven Walden Ventures Parallel V-B C.V. (“Pacven Parallel V-B”), Pacven Walden Ventures V Associates Fund, L.P. (“Pacven Associates V”), Pacven Walden Ventures V-QP Associates Fund, L.P. (“Pacven Associates V-QP”), Asian Venture Capital Investment Corp. (“Asian Venture”), International Venture Capital Investment Corp. (“International Venture”), International Venture Capital Investment III Corp. (“International Venture III”), Seed Ventures III Pte Ltd. (“Seed Ventures”), Pacven Walden Ventures VI, L.P. (“Pacven VI”), Pacven Walden Ventures Parallel VI, L.P. (“Pacven Parallel VI”), Lip-Bu Tan (“Tan”), Andrew Kau (“Kau”), Hock Voon Loo (“Loo”), Brian Chiang (“Chiang”) and Mary Coleman (“Coleman” and together with Pacven V, Pacven Parallel V-A, Pacven Parallel V-B, Pacven Associates V, Pacven Associates V-QP, Asian Venture, International Venture, International Venture III, Seed Ventures, Pacven VI, Pacven Parallel VI, Tan, Kau, Loo and Chiang, collectively, the “Reporting Persons”).  The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

(2)   On April 6, 2011, the reporting person sold 6,601 shares in a registered public offering and currently holds 52,609 shares of Common Stock, representing a beneficial ownership of 0.2%, calculated based upon 27,729,683 shares of Common Stock outstanding as of November 2, 2011 as set forth in the Issuer’s most recent 10-Q filed with the Securities and Exchange Commission on November 4, 2011.

(3)   This percentage is calculated based upon 25,388,810 shares of Common Stock outstanding as of February 23, 2011 as set forth in the Issuer’s most recent 10-K filed with the Securities and Exchange Commissions on March 7, 2011.

8

(1)   This Schedule 13G is filed by Pacven Walden Ventures V, L.P. (“Pacven V”), Pacven Walden Ventures Parallel V-A C.V. (“Pacven Parallel V-A”), Pacven Walden Ventures Parallel V-B C.V. (“Pacven Parallel V-B”), Pacven Walden Ventures V Associates Fund, L.P. (“Pacven Associates V”), Pacven Walden Ventures V-QP Associates Fund, L.P. (“Pacven Associates V-QP”), Asian Venture Capital Investment Corp. (“Asian Venture”), International Venture Capital Investment Corp. (“International Venture”), International Venture Capital Investment III Corp. (“International Venture III”), Seed Ventures III Pte Ltd. (“Seed Ventures”), Pacven Walden Ventures VI, L.P. (“Pacven VI”), Pacven Walden Ventures Parallel VI, L.P. (“Pacven Parallel VI”), Lip-Bu Tan (“Tan”), Andrew Kau (“Kau”), Hock Voon Loo (“Loo”), Brian Chiang (“Chiang”) and Mary Coleman (“Coleman” and together with Pacven V, Pacven Parallel V-A, Pacven Parallel V-B, Pacven Associates V, Pacven Associates V-QP, Asian Venture, International Venture, International Venture III, Seed Ventures, Pacven VI, Pacven Parallel VI, Tan, Kau, Loo and Chiang, collectively, the “Reporting Persons”).  The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

(2)   On April 6, 2011, the reporting person sold 6,601 shares in a registered public offering and currently holds 52,609 shares of Common Stock, representing a beneficial ownership of 0.2%, calculated based upon 27,729,683 shares of Common Stock outstanding as of November 2, 2011 as set forth in the Issuer’s most recent 10-Q filed with the Securities and Exchange Commission on November 4, 2011.

(3)   This percentage is calculated based upon 25,388,810 shares of Common Stock outstanding as of February 23, 2011 as set forth in the Issuer’s most recent 10-K filed with the Securities and Exchange Commissions on March 7, 2011.

9

(1)   This Schedule 13G is filed by Pacven Walden Ventures V, L.P. (“Pacven V”), Pacven Walden Ventures Parallel V-A C.V. (“Pacven Parallel V-A”), Pacven Walden Ventures Parallel V-B C.V. (“Pacven Parallel V-B”), Pacven Walden Ventures V Associates Fund, L.P. (“Pacven Associates V”), Pacven Walden Ventures V-QP Associates Fund, L.P. (“Pacven Associates V-QP”), Asian Venture Capital Investment Corp. (“Asian Venture”), International Venture Capital Investment Corp. (“International Venture”), International Venture Capital Investment III Corp. (“International Venture III”), Seed Ventures III Pte Ltd. (“Seed Ventures”), Pacven Walden Ventures VI, L.P. (“Pacven VI”), Pacven Walden Ventures Parallel VI, L.P. (“Pacven Parallel VI”), Lip-Bu Tan (“Tan”), Andrew Kau (“Kau”), Hock Voon Loo (“Loo”), Brian Chiang (“Chiang”) and Mary Coleman (“Coleman” and together with Pacven V, Pacven Parallel V-A, Pacven Parallel V-B, Pacven Associates V, Pacven Associates V-QP, Asian Venture, International Venture, International Venture III, Seed Ventures, Pacven VI, Pacven Parallel VI, Tan, Kau, Loo and Chiang, collectively, the “Reporting Persons”).  The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

(2)   On April 6, 2011, the reporting person sold 4,537 shares in a registered public offering and currently holds 36,168 shares of Common Stock, representing a beneficial ownership of 0.1%, calculated based upon 27,729,683 shares of Common Stock outstanding as of November 2, 2011 as set forth in the Issuer’s most recent 10-Q filed with the Securities and Exchange Commission on November 4, 2011.

(3)   This percentage is calculated based upon 25,388,810 shares of Common Stock outstanding as of February 23, 2011 as set forth in the Issuer’s most recent 10-K filed with the Securities and Exchange Commissions on March 7, 2011.

10

(1)   This Schedule 13G is filed by Pacven Walden Ventures V, L.P. (“Pacven V”), Pacven Walden Ventures Parallel V-A C.V. (“Pacven Parallel V-A”), Pacven Walden Ventures Parallel V-B C.V. (“Pacven Parallel V-B”), Pacven Walden Ventures V Associates Fund, L.P. (“Pacven Associates V”), Pacven Walden Ventures V-QP Associates Fund, L.P. (“Pacven Associates V-QP”), Asian Venture Capital Investment Corp. (“Asian Venture”), International Venture Capital Investment Corp. (“International Venture”), International Venture Capital Investment III Corp. (“International Venture III”), Seed Ventures III Pte Ltd. (“Seed Ventures”), Pacven Walden Ventures VI, L.P. (“Pacven VI”), Pacven Walden Ventures Parallel VI, L.P. (“Pacven Parallel VI”), Lip-Bu Tan (“Tan”), Andrew Kau (“Kau”), Hock Voon Loo (“Loo”), Brian Chiang (“Chiang”) and Mary Coleman (“Coleman” and together with Pacven V, Pacven Parallel V-A, Pacven Parallel V-B, Pacven Associates V, Pacven Associates V-QP, Asian Venture, International Venture, International Venture III, Seed Ventures, Pacven VI, Pacven Parallel VI, Tan, Kau, Loo and Chiang, collectively, the “Reporting Persons”).  The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

(2)   On April 6, 2011, the reporting person sold 89,683 shares in a registered public offering and currently holds 714,816 shares of Common Stock, representing a beneficial ownership of 2.6%, calculated based upon 27,729,683 shares of Common Stock outstanding as of November 2, 2011 as set forth in the Issuer’s most recent 10-Q filed with the Securities and Exchange Commission on November 4, 2011.

(3)   This percentage is calculated based upon 25,388,810 shares of Common Stock outstanding as of February 23, 2011 as set forth in the Issuer’s most recent 10-K filed with the Securities and Exchange Commissions on March 7, 2011.

11

(1)   This Schedule 13G is filed by Pacven Walden Ventures V, L.P. (“Pacven V”), Pacven Walden Ventures Parallel V-A C.V. (“Pacven Parallel V-A”), Pacven Walden Ventures Parallel V-B C.V. (“Pacven Parallel V-B”), Pacven Walden Ventures V Associates Fund, L.P. (“Pacven Associates V”), Pacven Walden Ventures V-QP Associates Fund, L.P. (“Pacven Associates V-QP”), Asian Venture Capital Investment Corp. (“Asian Venture”), International Venture Capital Investment Corp. (“International Venture”), International Venture Capital Investment III Corp. (“International Venture III”), Seed Ventures III Pte Ltd. (“Seed Ventures”), Pacven Walden Ventures VI, L.P. (“Pacven VI”), Pacven Walden Ventures Parallel VI, L.P. (“Pacven Parallel VI”), Lip-Bu Tan (“Tan”), Andrew Kau (“Kau”), Hock Voon Loo (“Loo”), Brian Chiang (“Chiang”) and Mary Coleman (“Coleman” and together with Pacven V, Pacven Parallel V-A, Pacven Parallel V-B, Pacven Associates V, Pacven Associates V-QP, Asian Venture, International Venture, International Venture III, Seed Ventures, Pacven VI, Pacven Parallel VI, Tan, Kau, Loo and Chiang, collectively, the “Reporting Persons”).  The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

(2)   On April 6, 2011, the reporting person sold 6,983 shares in a registered public offering and currently holds 55,659 shares of Common Stock, representing a beneficial ownership of 0.2%, calculated based upon 27,729,683 shares of Common Stock outstanding as of November 2, 2011 as set forth in the Issuer’s most recent 10-Q filed with the Securities and Exchange Commission on November 4, 2011.

(3)   This percentage is calculated based upon 25,388,810 shares of Common Stock outstanding as of February 23, 2011 as set forth in the Issuer’s most recent 10-K filed with the Securities and Exchange Commissions on March 7, 2011.

12

(1)       This Schedule 13G is filed by Pacven Walden Ventures V, L.P. (“Pacven V”), Pacven Walden Ventures Parallel V-A C.V. (“Pacven Parallel V-A”), Pacven Walden Ventures Parallel V-B C.V. (“Pacven Parallel V-B”), Pacven Walden Ventures V Associates Fund, L.P. (“Pacven Associates V”), Pacven Walden Ventures V-QP Associates Fund, L.P. (“Pacven Associates V-QP”), Asian Venture Capital Investment Corp. (“Asian Venture”), International Venture Capital Investment Corp. (“International Venture”), International Venture Capital Investment III Corp. (“International Venture III”), Seed Ventures III Pte Ltd. (“Seed Ventures”), Pacven Walden Ventures VI, L.P. (“Pacven VI”), Pacven Walden Ventures Parallel VI, L.P. (“Pacven Parallel VI”), Lip-Bu Tan (“Tan”), Andrew Kau (“Kau”), Hock Voon Loo (“Loo”), Brian Chiang (“Chiang”) and Mary Coleman (“Coleman” and together with Pacven V, Pacven Parallel V-A, Pacven Parallel V-B, Pacven Associates V, Pacven Associates V-QP, Asian Venture, International Venture, International Venture III, Seed Ventures, Pacven VI, Pacven Parallel VI, Tan, Kau, Loo and Chiang, collectively, the “Reporting Persons”).  The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

(2)       Includes: (i) 2,274,888 shares held by Pacven V, 52,423 shares held by Pacven Parallel V-A, 52,423 shares held by Pacven Parallel V-B, 5,576 shares held by Pacven Associates V, 36,672 shares held by Pacven Associates V-QP, 59,210 shares held by Asian Venture, 59,210 shares held by International Venture, 59,210 shares held by International Venture III, 40,705 shares held by Seed Ventures, and 804,499 shares held by Pacven VI, 62,642 shares held by Pacven Parallel VI. The reporting person is a director of Seed Ventures III Pte Ltd and the sole director and a member of the Investment Committee of Pacven Walden Management V Co. Ltd. (“Pacven Mgmnt V”) and Pacven Walden Management VI Co. Ltd. (“Pacven Mgmnt VI”).  Pacven Mgmnt V is the general partner of Pacven V, Pacven Parallel V-A, Pacven Parallel V-B, Pacven Associates V-QP and Pacven Associates V.  Pacven Mgmnt VI is the general partner of Pacven VI and Pacven Parallel VI. The reporting person is also a director of Asia Venture, International Venture and International Venture III.  The reporting person disclaims beneficial ownership of these partnerships’ shares except as to the reporting person’s pecuniary interest in the partnerships.

(3)       On April 5, 2011, the Reporting Persons indirectly sold an aggregate of 391,000 shares in a registered public offering and currently holds 3,120,440 shares of Common Stock, representing a beneficial ownership of 11.3%, calculated based upon 27,729,683 shares of Common Stock outstanding as of November 2, 2011 as set forth in the Issuer’s most recent 10-Q filed with the Securities and Exchange Commission on November 4, 2011.

(4)       This percentage is calculated based upon 25,388,810 shares of Common Stock outstanding as of February 23, 2011 as set forth in the Issuer’s most recent 10-K filed with the Securities and Exchange Commissions on March 7, 2011.

13

(1)       This Schedule 13G is filed by Pacven Walden Ventures V, L.P. (“Pacven V”), Pacven Walden Ventures Parallel V-A C.V. (“Pacven Parallel V-A”), Pacven Walden Ventures Parallel V-B C.V. (“Pacven Parallel V-B”), Pacven Walden Ventures V Associates Fund, L.P. (“Pacven Associates V”), Pacven Walden Ventures V-QP Associates Fund, L.P. (“Pacven Associates V-QP”), Asian Venture Capital Investment Corp. (“Asian Venture”), International Venture Capital Investment Corp. (“International Venture”), International Venture Capital Investment III Corp. (“International Venture III”), Seed Ventures III Pte Ltd. (“Seed Ventures”), Pacven Walden Ventures VI, L.P. (“Pacven VI”), Pacven Walden Ventures Parallel VI, L.P. (“Pacven Parallel VI”), Lip-Bu Tan (“Tan”), Andrew Kau (“Kau”), Hock Voon Loo (“Loo”), Brian Chiang (“Chiang”) and Mary Coleman (“Coleman” and together with Pacven V, Pacven Parallel V-A, Pacven Parallel V-B, Pacven Associates V, Pacven Associates V-QP, Asian Venture, International Venture, International Venture III, Seed Ventures, Pacven VI, Pacven Parallel VI, Tan, Kau, Loo and Chiang, collectively, the “Reporting Persons”).  The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

(2)       Includes: (i) 2,274,888 shares held by Pacven V, 52,423 shares held by Pacven Parallel V-A, 52,423 shares held by Pacven Parallel V-B, 5,576 shares held by Pacven Associates V, 36,672 shares held by Pacven Associates V-QP, 804,499 shares held by Pacven VI, and 62,642 shares held by Pacven Parallel VI.  The Reporting Person is a member of the Investment Committee of Pacven Walden Management V Co. Ltd. (“Pacven Mgmnt V”) and Pacven Walden Management VI Co. Ltd. (“Pacven Mgmnt VI”).  Pacven Mgmnt V is the general partner of Pacven V, Pacven Parallel V-A, Pacven Parallel V-B, Pacven Associates V-QP and Pacven Associates V.  Pacven Mgmnt VI is the general partner of Pacven VI and Pacven Parallel VI.  The reporting person disclaims beneficial ownership of these partnerships’ shares except as to the reporting person’s pecuniary interest in the partnerships.

(3)       On April 5, 2011, the Reporting Persons indirectly sold an aggregate of 366,660 shares in a registered public offering and currently holds 2,922,463 shares of Common Stock, representing a beneficial ownership of 10.5%, calculated based upon 27,729,683 shares of Common Stock outstanding as of November 2, 2011 as set forth in the Issuer’s most recent 10-Q filed with the Securities and Exchange Commission on November 4, 2011.

(4)       This percentage is calculated based upon 25,388,810 shares of Common Stock outstanding as of February 23, 2011 as set forth in the Issuer’s most recent 10-K filed with the Securities and Exchange Commissions on March 7, 2011.

14

(1)       This Schedule 13G is filed by Pacven Walden Ventures V, L.P. (“Pacven V”), Pacven Walden Ventures Parallel V-A C.V. (“Pacven Parallel V-A”), Pacven Walden Ventures Parallel V-B C.V. (“Pacven Parallel V-B”), Pacven Walden Ventures V Associates Fund, L.P. (“Pacven Associates V”), Pacven Walden Ventures V-QP Associates Fund, L.P. (“Pacven Associates V-QP”), Asian Venture Capital Investment Corp. (“Asian Venture”), International Venture Capital Investment Corp. (“International Venture”), International Venture Capital Investment III Corp. (“International Venture III”), Seed Ventures III Pte Ltd. (“Seed Ventures”), Pacven Walden Ventures VI, L.P. (“Pacven VI”), Pacven Walden Ventures Parallel VI, L.P. (“Pacven Parallel VI”), Lip-Bu Tan (“Tan”), Andrew Kau (“Kau”), Hock Voon Loo (“Loo”), Brian Chiang (“Chiang”) and Mary Coleman (“Coleman” and together with Pacven V, Pacven Parallel V-A, Pacven Parallel V-B, Pacven Associates V, Pacven Associates V-QP, Asian Venture, International Venture, International Venture III, Seed Ventures, Pacven VI, Pacven Parallel VI, Tan, Kau, Loo and Chiang, collectively, the “Reporting Persons”).  The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

(2)       Includes: (i) 2,274,888 shares held by Pacven V, 52,423 shares held by Pacven Parallel V-A, 52,423 shares held by Pacven Parallel V-B, 5,576 shares held by Pacven Associates V, 36,672 shares held by Pacven Associates V-QP, 59,210 shares held by International Venture, 40,705 shares held by Seed Ventures, 804,499 shares held by Pacven VI, and 62,642 shares held by Pacven Parallel VI.  The Reporting Person is a director and the liquidator of Seed Ventures III Pte Ltd and a member of the Investment Committee of Pacven Walden Management V Co. Ltd. (“Pacven Mgmnt V”) and Pacven Walden Management VI Co. Ltd. (“Pacven Mgmnt VI”).  Pacven Mgmnt V is the general partner of Pacven V, Pacven Parallel V-A, Pacven Parallel V-B, Pacven Associates V-QP and Pacven Associates V.  Pacven Mgmnt VI is the general partner of Pacven VI and Pacven Parallel VI.  The reporting person is also a director of International Venture.  The reporting person disclaims beneficial ownership of these partnerships’ shares except as to the reporting person’s pecuniary interest in the partnerships.

(3)       On April 5, 2011, the Reporting Persons indirectly sold an aggregate of 377,798 shares in a registered public offering and currently holds 3,011,240 shares of Common Stock, representing a beneficial ownership of 10.9%, calculated based upon 27,729,683 shares of Common Stock outstanding as of November 2, 2011 as set forth in the Issuer’s most recent 10-Q filed with the Securities and Exchange Commission on November 4, 2011.

(4)       This percentage is calculated based upon 25,388,810 shares of Common Stock outstanding as of February 23, 2011 as set forth in the Issuer’s most recent 10-K filed with the Securities and Exchange Commissions on March 7, 2011.

15

(1)       This Schedule 13G is filed by Pacven Walden Ventures V, L.P. (“Pacven V”), Pacven Walden Ventures Parallel V-A C.V. (“Pacven Parallel V-A”), Pacven Walden Ventures Parallel V-B C.V. (“Pacven Parallel V-B”), Pacven Walden Ventures V Associates Fund, L.P. (“Pacven Associates V”), Pacven Walden Ventures V-QP Associates Fund, L.P. (“Pacven Associates V-QP”), Asian Venture Capital Investment Corp. (“Asian Venture”), International Venture Capital Investment Corp. (“International Venture”), International Venture Capital Investment III Corp. (“International Venture III”), Seed Ventures III Pte Ltd. (“Seed Ventures”), Pacven Walden Ventures VI, L.P. (“Pacven VI”), Pacven Walden Ventures Parallel VI, L.P. (“Pacven Parallel VI”), Lip-Bu Tan (“Tan”), Andrew Kau (“Kau”), Hock Voon Loo (“Loo”), Brian Chiang (“Chiang”) and Mary Coleman (“Coleman” and together with Pacven V, Pacven Parallel V-A, Pacven Parallel V-B, Pacven Associates V, Pacven Associates V-QP, Asian Venture, International Venture, International Venture III, Seed Ventures, Pacven VI, Pacven Parallel VI, Tan, Kau, Loo and Chiang, collectively, the “Reporting Persons”).  The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

(2)       Includes: (i) 2,274,888 shares held by Pacven V, 52,423 shares held by Pacven Parallel V-A, 52,423 shares held by Pacven Parallel V-B, 5,576 shares held by Pacven Associates V, 36,672 shares held by Pacven Associates V-QP, 59,210 shares held by Asian Venture, 59,210 shares held by International Venture, 59,210 shares held by International Venture III, 804,499 shares held by Pacven VI, and 62,642 shares held by Pacven Parallel VI.  The Reporting Person is a member of the Investment Committee of Pacven Walden Management V Co. Ltd. (“Pacven Mgmnt V”) and Pacven Walden Management VI Co. Ltd. (“Pacven Mgmnt VI”).  Pacven Mgmnt V is the general partner of Pacven V, Pacven Parallel V-A, Pacven Parallel V-B, Pacven Associates V-QP and Pacven Associates V.  Pacven Mgmnt VI is the general partner of Pacven VI and Pacven Parallel VI. The reporting person is also the liquidator of Asian Ventures, International Venture and International Venture III.  The reporting person disclaims beneficial ownership of these partnerships’ shares except as to the reporting person’s pecuniary interest in the partnerships.

(3)       On April 5, 2011, the Reporting Persons indirectly sold an aggregate of 386,463 shares in a registered public offering and currently holds 3,080,290 shares of Common Stock, representing a beneficial ownership of 11.1%, calculated based upon 27,729,683 shares of Common Stock outstanding as of November 2, 2011 as set forth in the Issuer’s most recent 10-Q filed with the Securities and Exchange Commission on November 4, 2011.

(4)       This percentage is calculated based upon 25,388,810 shares of Common Stock outstanding as of February 23, 2011 as set forth in the Issuer’s most recent 10-K filed with the Securities and Exchange Commissions on March 7, 2011.

16

(1)       This Schedule 13G is filed by Pacven Walden Ventures V, L.P. (“Pacven V”), Pacven Walden Ventures Parallel V-A C.V. (“Pacven Parallel V-A”), Pacven Walden Ventures Parallel V-B C.V. (“Pacven Parallel V-B”), Pacven Walden Ventures V Associates Fund, L.P. (“Pacven Associates V”), Pacven Walden Ventures V-QP Associates Fund, L.P. (“Pacven Associates V-QP”), Asian Venture Capital Investment Corp. (“Asian Venture”), International Venture Capital Investment Corp. (“International Venture”), International Venture Capital Investment III Corp. (“International Venture III”), Seed Ventures III Pte Ltd. (“Seed Ventures”), Pacven Walden Ventures VI, L.P. (“Pacven VI”), Pacven Walden Ventures Parallel VI, L.P. (“Pacven Parallel VI”), Lip-Bu Tan (“Tan”), Andrew Kau (“Kau”), Hock Voon Loo (“Loo”), Brian Chiang (“Chiang”) and Mary Coleman (“Coleman” and together with Pacven V, Pacven Parallel V-A, Pacven Parallel V-B, Pacven Associates V, Pacven Associates V-QP, Asian Venture, International Venture, International Venture III, Seed Ventures, Pacven VI, Pacven Parallel VI, Tan, Kau, Loo and Chiang, collectively, the “Reporting Persons”).  The Reporting Persons expressly disclaim status as a “group” for purposes of this Schedule 13G.

(2)       Includes: (i) 2,274,888 shares held by Pacven V, 52,423 shares held by Pacven Parallel V-A, 52,423 shares held by Pacven Parallel V-B, 5,576 shares held by Pacven Associates V, 36,672 shares held by Pacven Associates V-QP, 804,499 shares held by Pacven VI, and 62,642 shares held by Pacven Parallel VI.  The Reporting Person is a member of the Investment Committee of Pacven Walden Management V Co. Ltd. (“Pacven Mgmnt V”) and Pacven Walden Management VI Co. Ltd. (“Pacven Mgmnt VI”).  Pacven Mgmnt V is the general partner of Pacven V, Pacven Parallel V-A, Pacven Parallel V-B, Pacven Associates V-QP and Pacven Associates V.  Pacven Mgmnt VI is the general partner of Pacven VI and Pacven Parallel VI.  The reporting person disclaims beneficial ownership of these partnerships’ shares except as to the reporting person’s pecuniary interest in the partnerships.

(3)       On April 5, 2011, the Reporting Persons indirectly sold an aggregate of 366,660 shares in a registered public offering and currently holds 2,922,463 shares of Common Stock, representing a beneficial ownership of 10.5%, calculated based upon 27,729,683 shares of Common Stock outstanding as of November 2, 2011 as set forth in the Issuer’s most recent 10-Q filed with the Securities and Exchange Commission on November 4, 2011.

(4)       This percentage is calculated based upon 25,388,810 shares of Common Stock outstanding as of February 23, 2011 as set forth in the Issuer’s most recent 10-K filed with the Securities and Exchange Commissions on March 7, 2011.

17

Introductory Note: This Statement on Schedule 13G is filed on behalf of the Reporting Persons, in respect of shares of Common Stock, par value $0.001 per share (“Common Stock”), of Inphi Corporation (the “Issuer”).

18

(1)   This percentage is calculated based upon 25,388,810 shares of Common Stock outstanding as of February 23, 2011 as set forth in the Issuer’s most recent 10-K filed with the Securities and Exchange Commissions on March 7, 2011.

19

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: February 1, 2012

20

21

Exhibit(s):

A - Joint Filing Statement

22

EXHIBIT A

JOINT FILING STATEMENT

We, the undersigned, hereby express our agreement that the attached Schedule 13G (or any amendments thereto) relating to the Common Stock of Inphi Corporation is filed on behalf of each of us.

Dated: February 1, 2012

23

24